I-PREVENT

Vaccine Injury

An Approach to Post-Vaccine Cardiovascular and Cancer Care

There is very limited data on the clinical features, pathogenetic mechanisms, and pathological findings of patients who have had delayed complications related to the COVID-19 vaccine. In addition, there is no published guidance on how to avoid these complications. This guidance is, therefore, based on our assessment of the likely pathogenic mechanisms underlying these delayed complications (spike protein-related disease) and the limited available autopsy data.

Post-Vaccine Cardiovascular Events and Cancer

Most serious adverse events following vaccination occur in the two weeks immediately following a dose of the vaccine. However, evolving data suggest that some patients who otherwise had no adverse events from the vaccine appear to have delayed acute cardiac events (often leading to sudden death). This appears to peak between 4 to 6 months after the vaccine but may extend for at least one year. There has also been evidence of an emergence of “turbo” and relapsed cancers in the months following vaccination. We have developed this document to attempt to limit these complications and reassure those who have been vaccinated. Essentially, both cardiac and cancer-related complications are related to the persistence of spike protein. Therefore, any intervention that reduces the persistence and the ‘load’ of spike protein will likely be beneficial.

Potential Treatment Approach
(see full protocol for more details, cautions and dosing information)

The primary approach to preventing delayed complications from vaccination is to enhance the body’s ability to eliminate spike protein. This is best achieved by practicing intermittent fasting/time-restricted eating and with a supplement like resveratrol, which activates autophagy and encourages the removal of spike protein. In addition, nattokinase, a naturally derived enzyme, breaks down extracellular spike protein and is a potent fibrinolytic agent, which breaks down blood clots. Furthermore, treating hyperinsulinemia likely limits both endothelial inflammation and carcinogenesis. We have added other interventions to this core treatment approach that likely have additional benefits. These include anti-platelet and fibrinolytic agents, which are central to the prevention of cardiovascular events following vaccination.

A suggested theoretical approach to limit the long-term complications of spike protein:

Intermittent fasting/time-restricted eating combined with a low-carbohydrate, high-fat diet (ketogenic diet), low in Omega-6 vegetable oils.

  • Nattokinase: 100-200 mg twice daily

  • Resveratrol: 500 mg daily

  • Aspirin (ASA): 81 mg daily (in those with low risk of bleeding)

  • Magnesium: 100-400 mg daily

  • Omega-3 fatty acids: 2-4 g daily

  • Co-enzyme Q (CoQ): 200-400 mg/day

  • Melatonin: 3-10 mg at night (slow release/extended release)

  • Bromelain: 500 mg twice daily +/- N-acetyl cysteine (NAC); 600 mg twice daily